AIRA

Boston, US · 1 known investors

AIRA is a platform that uses AI to support clinical development decision-making and study design for pharmaceutical and biotech companies. The company addresses inefficiencies in the drug development process by providing a unified, regulatory-grade system to help clinical teams design therapies faster and more safely.

AI & Machine LearningBiotechDigital HealthHealthtech